JP2003509408A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003509408A5 JP2003509408A5 JP2001523374A JP2001523374A JP2003509408A5 JP 2003509408 A5 JP2003509408 A5 JP 2003509408A5 JP 2001523374 A JP2001523374 A JP 2001523374A JP 2001523374 A JP2001523374 A JP 2001523374A JP 2003509408 A5 JP2003509408 A5 JP 2003509408A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- hydrogen
- pharmaceutically acceptable
- carbon atoms
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 16
- 125000000217 alkyl group Chemical group 0.000 claims 10
- 229910052739 hydrogen Inorganic materials 0.000 claims 9
- 239000001257 hydrogen Substances 0.000 claims 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 8
- 125000004432 carbon atom Chemical group C* 0.000 claims 7
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 6
- 239000004480 active ingredient Substances 0.000 claims 5
- 239000000825 pharmaceutical preparation Substances 0.000 claims 5
- 150000001768 cations Chemical class 0.000 claims 4
- 229910019142 PO4 Inorganic materials 0.000 claims 3
- 125000003277 amino group Chemical group 0.000 claims 3
- 238000010276 construction Methods 0.000 claims 3
- 239000010452 phosphate Substances 0.000 claims 3
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 2
- MQLACMBJVPINKE-UHFFFAOYSA-N 10-[(3-hydroxy-4-methoxyphenyl)methylidene]anthracen-9-one Chemical compound C1=C(O)C(OC)=CC=C1C=C1C2=CC=CC=C2C(=O)C2=CC=CC=C21 MQLACMBJVPINKE-UHFFFAOYSA-N 0.000 claims 1
- 208000007860 Anus Neoplasms Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 208000024770 Thyroid neoplasm Diseases 0.000 claims 1
- 102000004243 Tubulin Human genes 0.000 claims 1
- 108090000704 Tubulin Proteins 0.000 claims 1
- 210000000436 anus Anatomy 0.000 claims 1
- 201000011165 anus cancer Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 201000007455 central nervous system cancer Diseases 0.000 claims 1
- 210000001072 colon Anatomy 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 210000004072 lung Anatomy 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 230000001613 neoplastic effect Effects 0.000 claims 1
- 210000001672 ovary Anatomy 0.000 claims 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 claims 1
- 230000008685 targeting Effects 0.000 claims 1
- 201000002510 thyroid cancer Diseases 0.000 claims 1
- 210000001685 thyroid gland Anatomy 0.000 claims 1
- 210000004881 tumor cell Anatomy 0.000 claims 1
- 210000005166 vasculature Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15463999P | 1999-09-17 | 1999-09-17 | |
| US60/154,639 | 1999-09-17 | ||
| PCT/US2000/025408 WO2001019794A2 (en) | 1999-09-17 | 2000-09-15 | Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003509408A JP2003509408A (ja) | 2003-03-11 |
| JP2003509408A5 true JP2003509408A5 (enExample) | 2005-06-30 |
| JP4187441B2 JP4187441B2 (ja) | 2008-11-26 |
Family
ID=22552133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001523374A Expired - Fee Related JP4187441B2 (ja) | 1999-09-17 | 2000-09-15 | インドール含有およびコンブレタスタチン関連の抗有糸分裂および抗チューブリン重合薬剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20070082872A1 (enExample) |
| EP (1) | EP1214298B1 (enExample) |
| JP (1) | JP4187441B2 (enExample) |
| AU (1) | AU777725B2 (enExample) |
| CA (1) | CA2383988A1 (enExample) |
| WO (1) | WO2001019794A2 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004515452A (ja) * | 2000-05-09 | 2004-05-27 | アリゾナ ボード オブ リーゼンツ | アンチチュウブリンアセンブ称する細胞成長抑制剤 |
| BR0111230A (pt) | 2000-05-31 | 2003-06-10 | Astrazeneca Ab | Composto, e, uso e processo para a preparação do mesmo |
| AUPR283801A0 (en) * | 2001-02-01 | 2001-03-01 | Australian National University, The | Chemical compounds and methods |
| US7528165B2 (en) | 2001-12-13 | 2009-05-05 | National Health Research Institutes | Indole compounds |
| TWI317634B (en) | 2001-12-13 | 2009-12-01 | Nat Health Research Institutes | Aroyl indoles compounds |
| US7632955B2 (en) | 2001-12-13 | 2009-12-15 | National Health Research Institutes | Indole compounds |
| JP2005532280A (ja) | 2002-04-03 | 2005-10-27 | アストラゼネカ アクチボラグ | 化合物 |
| DE60336646D1 (de) | 2003-08-07 | 2011-05-19 | Nat Health Research Institutes | Indol-Verbindungen als Inhibitoren der Tubulin-Polymerisation zur Behandlung von angiogenesisbezogenen Erkrankungen |
| US7456214B2 (en) * | 2004-05-03 | 2008-11-25 | Baylor University | Chromene-containing compounds with anti-tubulin and vascular targeting activity |
| WO2006020573A2 (en) * | 2004-08-11 | 2006-02-23 | Barbeau Donald L | Noncardiotoxic pharmaceutical compounds |
| US7456289B2 (en) * | 2004-12-31 | 2008-11-25 | National Health Research Institutes | Anti-tumor compounds |
| CA2611712C (en) | 2005-06-14 | 2014-05-13 | Baylor University | Combretastatin analogs with tubulin binding activity |
| CA2640678C (en) | 2006-02-03 | 2015-03-31 | Bionomics Limited | Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors |
| US20100087446A1 (en) * | 2007-04-26 | 2010-04-08 | Chakravarty Prasun K | 2-substituted indole derivatives as calcium channel blockers |
| CN106822083A (zh) | 2009-08-27 | 2017-06-13 | 生物学特性有限公司 | 用于治疗增生性疾病的联合疗法 |
| JP2013502440A (ja) | 2009-08-27 | 2013-01-24 | バイオノミックス リミテッド | 黄斑変性の治療 |
| IT1399130B1 (it) | 2010-04-01 | 2013-04-05 | Consiglio Nazionale Ricerche | Derivati indolici e loro uso in campo medico. |
| US9353150B2 (en) | 2012-12-04 | 2016-05-31 | Massachusetts Institute Of Technology | Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment |
| WO2014144715A1 (en) | 2013-03-15 | 2014-09-18 | Memorial Sloan-Kettering Cancer Center | Hsp90-targeted cardiac imaging and therapy |
| CN104098499B (zh) * | 2013-04-08 | 2016-05-04 | 上海医药工业研究院 | 5-苄氧基-2-(4-苄氧基苯基)-3-甲基-1h-吲哚的制备方法 |
| US9944597B2 (en) | 2013-09-16 | 2018-04-17 | The Board Of Regents Of The University Of Texas System | Polysubstituted pyrroles having microtubule-disrupting, cytotoxic and antitumor activities and methods of use thereof |
| CN104262229B (zh) * | 2014-08-18 | 2016-10-05 | 广东颐正达医药科技有限公司 | 一种2-苯基取代-3-苯甲酰基取代吲哚的制备方法 |
| US10918627B2 (en) | 2016-05-11 | 2021-02-16 | Massachusetts Institute Of Technology | Convergent and enantioselective total synthesis of Communesin analogs |
| US11932650B2 (en) | 2017-05-11 | 2024-03-19 | Massachusetts Institute Of Technology | Potent agelastatin derivatives as modulators for cancer invasion and metastasis |
| CN107652194B (zh) * | 2017-08-08 | 2020-02-28 | 首都医科大学附属北京天坛医院 | 一类用于治疗神经系统疾病的化合物 |
| US10640508B2 (en) | 2017-10-13 | 2020-05-05 | Massachusetts Institute Of Technology | Diazene directed modular synthesis of compounds with quaternary carbon centers |
| WO2020247054A1 (en) | 2019-06-05 | 2020-12-10 | Massachusetts Institute Of Technology | Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof |
| WO2022182415A1 (en) | 2021-02-24 | 2022-09-01 | Massachusetts Institute Of Technology | Himastatin derivatives, and processes of preparation thereof, and uses thereof |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2963288B2 (ja) * | 1992-01-14 | 1999-10-18 | 株式会社海洋バイオテクノロジー研究所 | 水中有害付着生物防除剤 |
| US5596106A (en) * | 1994-07-15 | 1997-01-21 | Eli Lilly And Company | Cannabinoid receptor antagonists |
| US5886025A (en) * | 1997-03-06 | 1999-03-23 | Baylor University | Anti-mitotic agents which inhibit tubulin polymerization |
| US5948808A (en) * | 1997-03-07 | 1999-09-07 | The Texas A&M University System | Indole-3-carbinol, diindolylmethane and substituted analogs as antiestrogens |
| US6150395A (en) * | 1997-05-30 | 2000-11-21 | The Regents Of The University Of California | Indole-3-carbinol (I3C) derivatives and methods |
| US6001868A (en) * | 1997-05-30 | 1999-12-14 | The Regents Of The University Of California | Indole-3-carbinol (I3C) derivatives and methods |
| WO1999034788A1 (en) * | 1998-01-09 | 1999-07-15 | Arizona Board Of Regents, A Body Corporate, Acting On Behalf Of Arizona State University | Synthesis of phenstatin and prodrugs thereof |
| US6410584B1 (en) * | 1998-01-14 | 2002-06-25 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells with indole derivatives |
| US6162930A (en) * | 1998-03-06 | 2000-12-19 | Baylor University | Anti-mitotic agents which inhibit tubulin polymerization |
| DE19946301A1 (de) * | 1998-04-02 | 2001-04-19 | Asta Medica Ag | Indolyl-3-glyoxylsäure-Derivate mit therapeutisch wertvollen Eigenschaften |
| DE19814838C2 (de) * | 1998-04-02 | 2001-01-18 | Asta Medica Ag | Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung |
| US6110963A (en) * | 1998-05-12 | 2000-08-29 | American Home Products Corporation | Aryl-oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| US6166069A (en) * | 1998-05-12 | 2000-12-26 | American Home Products Corporation | Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| US6358992B1 (en) * | 1998-11-25 | 2002-03-19 | Cell Pathways, Inc. | Method of inhibiting neoplastic cells with indole derivatives |
| WO2000048606A1 (en) * | 1999-02-18 | 2000-08-24 | Oxigene, Inc. | Compositions and methods for use in targeting vascular destruction |
| US6521658B1 (en) * | 1999-05-28 | 2003-02-18 | Abbott Laboratories | Cell proliferation inhibitors |
| US6849656B1 (en) * | 1999-09-17 | 2005-02-01 | Baylor University | Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents |
| US6323228B1 (en) * | 2000-09-15 | 2001-11-27 | Abbott Laboratories | 3-substituted indole angiogenesis inhibitors |
-
2000
- 2000-09-15 JP JP2001523374A patent/JP4187441B2/ja not_active Expired - Fee Related
- 2000-09-15 WO PCT/US2000/025408 patent/WO2001019794A2/en not_active Ceased
- 2000-09-15 EP EP00963531A patent/EP1214298B1/en not_active Expired - Lifetime
- 2000-09-15 AU AU74934/00A patent/AU777725B2/en not_active Ceased
- 2000-09-15 CA CA002383988A patent/CA2383988A1/en not_active Abandoned
-
2004
- 2004-05-03 US US10/555,352 patent/US20070082872A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2407967A1 (en) | Tubulin binding ligands and corresponding prodrug constructs | |
| IL319022A (en) | PSMA imaging and endoradiotherapy ligands | |
| AU634450B2 (en) | Boronated nucleosides | |
| ES2167451T3 (es) | O6-benzilguaninas sustituidas. | |
| HRP20160430T1 (hr) | Nova grupa inhibitora stat3 puta i inhibitora puta matičnih stanica karcinoma | |
| US7078552B2 (en) | Combretastatin A-1 phosphate and combretastatin B-1 phosphate prodrugs | |
| JP2019512478A5 (enExample) | ||
| JP2004522694A5 (enExample) | ||
| ES2147646T3 (es) | Composiciones para diagnostico, prevencion y tratamiento de la progresion de los tumores. | |
| CA2133323A1 (en) | Self-assembling polynucleotide delivery system | |
| JP2014525464A5 (enExample) | ||
| EP1018548A4 (en) | COMPOSITION BASED ON GLYCOSYLCERAMIDE ALPHA CAPABLE OF POTENTIALIZING CELLULAR IMMUNOGENICITY | |
| RU2000125889A (ru) | Замещенные бисиндолималеимиды, предназначенные для ингибирования пролиферации клеток | |
| JP2004517882A5 (enExample) | ||
| CA2380022A1 (en) | Aromatic esters of camptothecins and methods to treat cancers | |
| IL137964A0 (en) | Antitumor agents | |
| Burnham | Synthesis and pharmacological activities of amine-boranes | |
| US8383605B2 (en) | Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals | |
| RU2009124622A (ru) | Новые гидрофильные производные 2-арил-4-хинолонов в качестве противораковых агентов | |
| US11066421B1 (en) | Synthetic cinchona alkaloids against cancer | |
| NO20011817L (no) | Ionebytte-tumormålsöking (IETT) | |
| US6392068B1 (en) | Carborane containing cholesterol, a new type of molecule for targeted boron drug delivery | |
| CA2375513A1 (en) | 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides | |
| CA2398643A1 (en) | Novel compounds | |
| Stadlbauer et al. | Imitation and modification of bioactive lead structures via integration of boron clusters |